Merck KGaA

In News

Merck KGaA improves guidance with strong third quarter results - The Pharma Letter

The Pharma Letter - Jan 08, 2026

Does Merck KGaA’s Rebound Reflect Its True Value After AI Partnership And CEO Change News - Yahoo Finance

Yahoo Finance - Dec 18, 2025

The 'Knockout' Hit That Sent This Top 3% Biotech Stock Flying - Investor's Business Daily

Investor's Business Daily - Dec 15, 2025

Merck KGaA ventures into new territory in the US - Pharma Voice

Pharma Voice - Aug 15, 2025

Merck KGaA: Driving Quality Transformation Across the Enterprise - Veeva

Veeva - Dec 10, 2025

Hakan Goker Discusses M Ventures’ Strategic Investments in Biotech Innovation and Vision for 2026 - geneonline.com

geneonline.com - Jan 09, 2026

China’s First-in-Class TGCT Drug Approval Might Change The Case For Investing In Merck (XTRA:MRK) - simplywall.st

simplywall.st - Jan 05, 2026

Immunome’s rare tumor drug passes Phase 3 test, could challenge Merck KGaA - Endpoints News

Endpoints News - Dec 15, 2025

Merck KGaA's Q3 profit rises, beats market view - Reuters

Reuters - Nov 12, 2025

TrumpRx welcomes Merck KGaA, one of nine to receive new priority voucher - FirstWord

FirstWord - Oct 16, 2025

Merck KGaA eyes new Parkinson’s disease assets with $3bn Valo partnership - Pharmaceutical Technology

Pharmaceutical Technology - Nov 20, 2025

Quarterly sales edge up for Merck KGaA, but 2017 outlook hit by exchange rate changes - The Pharma Letter

The Pharma Letter - Jan 08, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment